152 related articles for article (PubMed ID: 9839198)
1. Total antioxidant capacity (TAC): is it an effective method to evaluate the oxidative stress in uraemia?
Bergesio F; Monzani G; Ciuti R; Pinzani P; Fiaschi N; Priami F; Cirami C; Ciccarelli C; Salvadori M
J Biolumin Chemilumin; 1998; 13(5):315-9. PubMed ID: 9839198
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids.
Bergesio F; Monzani G; Ciuti R; Cirami C; Martinelli F; Salvadori M; Tosi PL
Nephron; 2001 Feb; 87(2):127-33. PubMed ID: 11244306
[TBL] [Abstract][Full Text] [Related]
3. Lp(a) levels: effects of progressive chronic renal failure and dietary manipulation.
Monzani G; Bergesio F; Ciuti R; Ciciani AM; Martinelli F; Rosati A; Salvadori M
J Nephrol; 1997; 10(1):41-5. PubMed ID: 9241624
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.
Bergesio F; Monzani G; Guasparini A; Ciuti R; Gallucci M; Cristofano C; Castrignano E; Cupisti A; Barsotti G; Marcucci R; Abbate R; Bandini S; Gallo M; Tosi PL; Salvadori M
Clin Nephrol; 2005 Aug; 64(2):103-12. PubMed ID: 16114786
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
6. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
7. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B
Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417
[TBL] [Abstract][Full Text] [Related]
8. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
Montazerifar F; Hashemi M; Karajibani M; Dikshit M
J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
12. Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure.
Samouilidou E; Grapsa E
Blood Purif; 2003; 21(3):209-12. PubMed ID: 12784045
[TBL] [Abstract][Full Text] [Related]
13. Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study.
Mekki K; Taleb W; Bouzidi N; Kaddous A; Bouchenak M
Lipids Health Dis; 2010 Sep; 9():93. PubMed ID: 20815897
[TBL] [Abstract][Full Text] [Related]
14. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
16. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Navarro JF; Mora C; Muros M; García-Idoate G
Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
[TBL] [Abstract][Full Text] [Related]
18. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study.
Zakar G;
Wien Klin Wochenschr; 2001 Sep; 113(17-18):688-94. PubMed ID: 11603104
[TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
20. Reduced oxidative stress in hypoalbuminemic CAPD patients.
Kim SB; Yang WS; Min WK; Lee SK; Park JS
Perit Dial Int; 2000; 20(3):290-4. PubMed ID: 10898045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
